DelsiTech Ltd is a Finnish clinical-stage drug delivery technology company specializing in long-acting injectable formulations using its proprietary biodegradable Silica Matrix platform. The company develops its own pipeline of long-acting injectable products for metabolic disease and pain, and licenses its Silica Matrix technology to pharmaceutical partners. DelsiTech is a drug delivery technology licensor and development-stage company, not a contract manufacturer.
Silica Matrix drug delivery platform, long-acting injectables, controlled-release formulations, drug delivery licensing
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.